• Acorda Therapeutics Inc., of Ardsley, N.Y., beat analyst estimates with its net revenues hitting $81.5 million for the fourth quarter vs. the $79.8 million consensus. The company reported GAAP net income of $133 million for the quarter ended Dec. 31, 2012, or $3.27 per diluted EPS.